Biovac’s manufacturing facilities are located in Cape Town. We subscribe to current Good Manufacturing Practice (cGMP). Our facilities boast the following capabilities:
| Capabilities | Licensed | Additional |
|---|---|---|
| Upstream Processing | Bacterial fermentation | |
| Downstream Processing | Polysaccharide and Protein Purification Conjugation |
|
| Formulation | In disposable and fixed vessels | |
| Filling | In vials | Filling in prefilled syringes |
| Inspection, Labelling & Packaging | Manual
Automated |
|
| Quality Control | Microbiological testing Chemical testing and analysis Sterility testing |
In our Quality Policy, we undertake to develop, consistently produce and deliver safe, efficacious and quality-assured products that comply with customer and regulatory requirements. We also pledge to ensure continual improvement of our Pharmaceutical Quality System.
Our current sterile manufacturing efforts are related to Hexavalent vaccine and Pneumo-conjugate vaccines with our partners, Sanofi Pasteur and Pfizer respectively.
In a bid for security of supply and self-sustainability, we continue to procure licensing for all our capabilities.